在CAR上对瘤性VSV的特定负载增强了CAR-T细胞信号和抗瘤活动
Fan Xing1,2, Xuemei Wang3, Zeying Li1
1Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou, China.
The Journal of experimental medicine
|September 12, 2025
概括
这项研究引入了一种新的仿真抗原受体 (CAR) T细胞策略,以改善对固体瘤的瘤病毒 (OV) 治疗. 改造的CAR T细胞增强病毒传递和CAR T细胞活性,促进抗瘤免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- 瘤病毒 (OV) 和仿真抗原受体 (CAR) T 细胞显示出对固体瘤治疗的希望.
- 由于病毒感染,联合疗法受到不均的分布和CAR T细胞枯竭的阻碍.
研究的目的:
- 设计一种CAR分量,该分量专门将囊性口腔炎病毒 (VSV) 突变 (VSVΔ51) 载入并传递给瘤组织.
- 加强CAR T细胞激活,增殖和抗瘤功效,当与OVs结合使用时.
主要方法:
- 设计了一个CAR部分 (CR2/3-CAR),其中包含VSVΔ51.1.的病毒受体域 (CR2和CR3).
- 将VSVΔ51装载到设计的CAR T-细胞上以进行有针对性的传输.
- 研究了病毒包膜蛋白和CR2/3-CAR对T细胞激活的相互作用.
主要成果:
- 设计的CAR T细胞成功加载并释放VSVΔ51,从而实现了高效的瘤输送.
- 病毒-CAR T细胞相互作用通过形成CAR集群和突触预激活了CAR T细胞.
- 观察到增强的CAR T细胞增殖,代谢适应性和免疫活性.
结论:
- 开发的策略有效地克服了OV/CAR T细胞联合治疗的局限性.
- 这种方法显著提高了协同作用的抗瘤细胞毒性,为固体瘤治疗提供了一个有前途的策略.
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K